Sentences with phrase «on application programming»

Currently, I am a junior at Logon City College pursuing a Bachelor of Science in Information Technology with a focus on application programming.

Ensure you specify on your application the program and day (s) for which you are interested in volunteering.

Not exact matches

The other essential program, one Accurate Drafting has depended on for close to five years now, is Minute7, a cloud - based timesheet application that integrates with QuickBooks.

Whole Foods Market is helping independent local producers expand and grow their businesses through its Local Producer Loan Program, which lends up to $ 10 million annually and accepts applications on a rolling basis.

The launch of Lotus 1 -2-3 had disrupted the monopoly VisiCorp's spreadsheet program was enjoying, and had set the standard for productivity applications on personal computers.

Despite growing fears that Harvard Business School has turned its back on financiers and consultants, it's more likely that recently rejected applicants to the elite MBA program fell victim to common application fumbles.

For example, many content - management systems have add - ons or plug - ins for mobile or social applications, such as a program that allows visitors to use their saved profile to register with your website rather than creating a new one.

Clio first opened up the platform in 2012 and in the past year «really doubled down» on its positioning, introducing a new application programming interface (API) that presented additional opportunities for developers.

«The Commission will not take adverse action on a license renewal application based upon the subjective determination of a listener or group of listeners that the station has broadcast purportedly inappropriate programming,» the FCC commissioners wrote in a recent decision challenging a local radio station license.

Computers, programmed to verify the accuracy of the information on a loan application, will then decide yea or nay on the loan.

As Microsoft's Windows demonstrated in the PC era, technology markets in which third - party companies build programs or applications to run on top of a particular operating system or other product --» platform markets» — tend to standardize around one or two market leaders.

Just use a service like Extole to create a referral system built into your application, complete with incentive programs and quality landing pages to drive new customers, all with minimal work on your end.

It's too soon to know whether the pilot program introduced by Adams National Bank — loan officers» making «house calls» to prospective business borrowers and processing credit applications on laptops — will prove to be an enlightened solution to that chronic problem.

It's modeled on a popular computer programming technique called rapid application development, or RAD, which relies on prototyping and iterative improvements to complete a project.

Such programs tout their ability to give workers a single sign - on, one login for access to their corporate network, e-mail, and applications.

Templates for VisiCalc, SuperCalc, and other popular programs include tax - preparation models from Professional Software Technology (priced at $ 49, $ 99, and $ 149; P.O. Box 269, Rockport, MA 01966) and agricultural applications created by AgriSoft ($ 19.95 per disk; Suite 202, 1001 E. Walnut St., Columbia, MO 65201) VisiCalc's publisher, VisiCorp, recently issued its own set of seven interrelated applications worksheets; available on a single disk under the title «VisiCalc Business Forecasting Model» ($ 100) are such easily filled templates as Income Statement, Statement of Cash Flow, and Cost of Goods Sold.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Over the course of the program you will focus on specific topics and application to real business situations and problems, making your learning immediately applicable.

Loan applications are accepted on an ongoing basis, independent of acceptance into the business and management education program.

As part of the application process, entrepreneurs must enter into a collaborative agreement with UMSL that describes how they will further the mission and goals of UMSL (such as by hiring or mentoring students, developing programs, contributing to academic research, etc., depending on school needs).

Ethereum seemed like a natural choice, with its popularity and its very general Solidity contract language,» said Watkinson, referring to the code behind EDCCs on Ethereum, which can be programmed to suit a number of applications.

To this end, it offers short - term Junior Research Fellowships on an ongoing basis to Canadians who are currently enrolled in undergraduate or master's - level programs, or who have completed their degree programs within 12 months of the application deadline.

The second phase of the program focuses on developing strategic perspectives and application to a dynamic global environment.

Application deadline for the 2018 - 19 program closed 9:00 a.m. on April, 30, 2018.

Online applications to join LOT are open all year and due on April 30 of each year for the upcoming program year which runs from September to August.

It focuses on running the programming code of any decentralized application.

Developers can create applications that run on the EVM using friendly programming languages modelled on existing languages like JavaScript and Python.

It provides thousands of on - demand courses focusing on popular programming languages, application development platforms, developer tools, and more.

Applications for this program are evaluated on an annual basis, so look up the current application deadline here.

With a focus on driving innovation to deliver leading - edge solutions for its clients and support the Canadian innovation community, RBC is the first Canadian bank to launch an Application Programming Interface (API) developer portal...

The first focuses on ideation and product market fit, the second teaches the technology tools required to build the company such as CAD and iOS / Android programming, and the third focuses on marketing and sales applications.

Clear / comprehensive Terms and Conditions — affiliates should easily understand where your program stands on trademark bidding, direct linking, downloadable applications, etc..

To be eligible for this program, Arizona homeowners must be current on their mortgage payments at the time of application.

The Hong Kong Monetary Authority (HKMA) issued a consultation on Open API framework, setting out the HKMA's intended approach to Open Application Programming Interfaces (API) for the banking industry in Hong Kong.

All applications are reviewed and considered based on needs of the program and to ensure diverse industry representation that reflects our membership.

The program will focus on high - quality applications and not the quantity of applicants.

The EYE program is a year long commitment with 5 - days of hands on training and practical application.

Third - party apps rely on being able to access data from Instagram's API (application programming interface).

The TWQ (Tawarruq) is an ERC20 token that confer the right to the token holder to submit an application for a personal financing based on a Commodity Tawarruq Trading program, through the iP2PGlobal platform and have it listed in the platform for prospective lenders to view and choose to finance.

We, on the other hand, support the single - application programming interface (or API) connection that is critical for e-commerce platforms and vendors, as well as different currency programs for them.

Many iOS programs and applications on the App store have been infected with a malware called XcodeGhost.

In another editorial he argues that the church should promote such concrete programs as Social Security, Medicare, the Jobs Corps, and the massive attack on the intolerable slums of our great cities.35 These are concrete applications of Scripture's moral principles, viewed in light of contemporary social and economic reality.

Spelled out in a lengthy lead editorial entitled «Evangelicals in the Social Struggle,» as well as in books such as Aspects of Christian Social Ethics, Henry's understanding of Christian social responsibility stressed (a) society's need for the spiritual regeneration of all men and women, (b) an interim social program of humanitarian care, ethical proclamation, and personal, structural application, and (c) a theory of limited government centering on certain «freedom rights,» e. g., the rights to public property, free speech, and so on.18 Though the shape of this social ethic thus closely parallels that of the present editorial position of Moody Monthly, it must be distinguished from its counterpart by the time period involved (it pushed others like Moody Monthly into a more active involvement in the social arena), by the intensity of its commitment to social responsibility, by the sophistication of its insight into political theory and practice, and by its willingness to offer structural critique on the American political system.

More significantly, these studies tended to focus on «how - to» concerns, or the application of what was taught in the «theoretical» fields of biblical, historical and theological - ethical studies (each also separate from the others and supported by its own professional associations, journals, degree programs and faculties).

The Church Growth Movement has picked up on this consumer emphasis in society, and by the application of marketing analysis and technology can help churches grow by identifying the major demands people are making and tailoring your church to meet those demands: right down to the type of minister needed, the types of programs that should be offered, the type of theology to preach, the best places to build, and the most productive market segment to aim for.

Commodore Plastics, on the other hand, is capable of developing premium tray programs for customers made specifically for their particular applications.

For other staff — many of them of the technology - driven age — Jablow has created a program where employees can download applications that train them on different stations in the restaurant.

In addition, an updated Let's Move Salad Bars to School site was recently launched to provide a portal for school districts to submit applications to receive a salad bar and for information on how to include a salad bar in their school meal program.

This website includes information on the application process for the acclaimed Coca - Cola scholars program.

With technical and scientific classroom education, practical laboratory applications, and hands on brewing and distilling experience, including recipe development, the PBDT program gives the graduate an employable advantage in the industry.